This is actually a regulatory rollback. During the emergency authorization, pharmacists could administer without physician oversight to scale distribution quick

This is actually a regulatory rollback. During the emergency authorization, pharmacists could administer without physician oversight to scale distribution quickly. Moving back to normal approval processes means more friction but theoretically better safety monitoring. The question is whether the infrastructure exists to handle the consultation volume.